文献速递冠心病外科

冠状动脉血运重建中单侧与双侧乳内动脉的比较:是时候改变了吗?

Coronary Revascularization With Single Versus Bilateral Mammary Arteries: Is It Time to Change?
PubMed 文献 · Ann Thorac Surg · 2018-03-14

基于1992至2014年区域登记中47984例单纯冠状动脉旁路移植术患者,将1482例双侧乳内动脉(BIMA)患者中的1297例与单侧乳内动脉(SIMA)患者进行倾向匹配。BIMA与SIMA围术期不良事件无差异,但BIMA长期生存更优(校正HR 0.79,95%CI 0.69-0.91,p<0.001),15年生存绝对差异8.4%。作者认为BIMA应更频繁地被考虑。

要点

  • BIMA与SIMA围术期死亡、卒中、出血和纵隔炎均无显著差异。
  • BIMA长期生存优于SIMA(校正HR 0.79,95%CI 0.69-0.91,p<0.001)。
  • 生存曲线在5年后开始分离,15年生存绝对差异为8.4%。

核心结论

  • 在大规模区域经验中,BIMA与SIMA相比不增加围术期不良事件风险,且长期生存更优。
  • 作者认为,鉴于BIMA显示出生存优势,在冠状动脉旁路移植术中应更频繁地考虑使用BIMA。

研究设计与样本

  • 研究基于区域连续开胸手术登记,纳入1992至2014年47984例单纯冠状动脉旁路移植术患者。
  • 1482例BIMA患者中的1297例与SIMA患者进行倾向匹配。
  • 围术期结局采用标准统计方法比较,长期生存采用Kaplan-Meier估计和log-rank检验比较。

主要发现

  • BIMA患者较SIMA患者更年轻且合并症更少。
  • 倾向加权后BIMA与SIMA患者匹配良好。
  • 围术期结局BIMA vs SIMA:死亡1.2%(n=15)vs 0.8%(n=10),p=0.315;卒中0.7%(n=9)vs 0.7%(n=9),p=1.000;出血2.2%(n=28)vs 2.8%(n=36),p=0.311;纵隔炎0.8%(n=10)vs 0.9%(n=12),p=0.667。
  • 中位随访12年,BIMA生存优于SIMA(校正风险比0.79;95%置信区间0.69至0.91;p<0.001)。
  • 生存曲线在5年后开始分离,15年时生存绝对差异为8.4%。

临床怎么用

  • 作者认为,由于BIMA显示出生存优势,在冠状动脉旁路移植术中应更频繁地考虑使用BIMA。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arterial conduits are preferred to venous conduits for coronary artery bypass grafting because of longer patency. A single internal mammary artery (SIMA) is used routinely. Bilateral internal mammary arteries (BIMA) are used less frequently. We sought to determine whether BIMA were superior to SIMA. METHODS: From our regional registry of consecutive open heart operations, we identified 47,984 patients who underwent isolated coronary artery bypass grafting from 1992 to 2014. Of the 1,482 BIMA patients, 1,297 were propensity matched to a cohort of SIMA patients. Short-term outcomes were compared using standard statistical techniques. Long-term survival was compared using Kaplan-Meier estimators and compared using a log-rank test. RESULTS: BIMA patients were younger and had fewer comorbid conditions than SIMA patients. After propensity weighting, BIMA and SIMA patients were well matched. There was no difference in in-hospital outcomes for BIMA versus SIMA patients for mortality (1.2% [n = 15] vs 0.8% [n = 10], p = 0.315), stroke (0.7% [n = 9] vs 0.7% [n = 9), p = 1.000), bleeding (2.2% [n = 28] vs 2.8% [n = 36], p = 0.311), or mediastinitis (0.8% [n = 10] vs 0.9% [n = 12], p = 0.667). The median follow-up was 12 years. Survival was better for BIMA than SIMA (adjusted hazard ratio, 0.79; 95% confidence interval, 0.69 to 0.91; p < 0.001). Survival curves began to separate after 5 years. At 15 years, the absolute difference in survival was 8.4%. CONCLUSIONS: In a large regional experience, BIMA is associated with no upfront risk of adverse events and improved long-term survival compared with SIMA. Our results indicate that BIMA conduits should be considered more frequently during coronary artery bypass grafting due to their demonstrated survival advantage.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. DeSimone JP, Malenka DJ, Weldner PW, et al. Coronary Revascularization With Single Versus Bilateral Mammary Arteries: Is It Time to Change? Ann Thorac Surg. 2018. PMID: 29550203. doi:10.1016/j.athoracsur.2018.01.089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。